Clebopride
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 4-amino-N-(1-benzylpiperidin-4-yl)-5-chloro- 2-methoxybenzamide |
|
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 55905-53-8 |
| ATC code | A03FA06 |
| PubChem | CID 2780 |
| ChemSpider | 2678 |
| UNII | I0A84520Y9 |
| KEGG | D03534 |
| ChEMBL | CHEMBL325109 |
| Chemical data | |
| Formula | C20H24ClN3O2 |
| Mol. mass | 373.876 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
Clebopride is a dopamine antagonist drug with antiemetic and prokinetic properties used to treat functional gastrointestinal disorders. Chemically, it is a substituted benzamide, closely related to metoclopramide.
A small Spanish study found that more adverse reactions are reported with clebopride than with metoclopramide, particularly extrapyramidal symptoms.[1]
[edit] References
- ^ Cuena Boy R, Maciá Martínez MA (1998). "[Extrapyramidal toxicity caused by metoclopramide and clebopride: study of voluntary notifications of adverse effects to the Spanish Drug Surveillance System]" (in Spanish). Atencion Primaria 21 (5): 289–95. PMID 9608114. Free full text
|
| This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |

